JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Advances in the epidemiology of gestational trophoblastic disease.

Recent reports on the incidence of hydatidiform mole and choriocarcinoma are reviewed, with consideration of the methodologic difficulties of obtaining accurate rates. The incidence of hydatidiform mole appears to be about 1 per 1,000 pregnancies in most parts of the world and perhaps twice as high in Japan. Choriocarcinoma is much less common, and estimates of the incidence are highly variable. Maternal age and a history of hydatidiform mole have been established as strong risk factors for both hydatidiform mole and choriocarcinoma. The evidence for a role of other factors, including diet, ethnicity, endogenous estrogen levels, ABO blood group and environmental toxins, is weaker.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.
Urinary Tract Infections: Core Curriculum 2024.American Journal of Kidney Diseases 2023 October 31

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app